SCHEMBL6238037

SCHEMBL6238037

Clc1ccc(Nc2cc(Nc3ccccc3)nc3ccccc23)cc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.60
SLC2A1 P11166 2/20 0.49
POLA1 P09884 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 1/20 0.46
ACP1 P24666 3/20 0.46
LMNA P02545 2/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.45
RAB9A P51151 1/20 0.45
KDR P35968 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
ABCG2 Q9UNQ0 2/20 0.44
FADS1 O60427 1/20 0.44
ABCB1 P08183 1/20 0.43
NPC1 O15118 1/20 0.43
GUSB P08236 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6233775 0.86 SLC2A1 (0.50) NPY5RSLC2A1POLA1MEN1KMT2A
SCHEMBL6230099 0.86 L3MBTL1 (0.51) NPY5RSLC2A1POLA1MEN1KMT2A
SCHEMBL6234079 0.86 SLC2A1 (0.50) NPY5RSLC2A1MEN1KMT2APOLB
SCHEMBL6238255 0.86 NPY5R (0.51) NPY5RSLC2A1POLA1MEN1KMT2A
SCHEMBL6235130 0.86 MAPT (0.48) NPY5RSLC2A1POLA1MEN1KMT2A
SCHEMBL6233063 0.86 SLC2A1 (0.71) NPY5RSLC2A1MEN1KMT2ASMN1; SMN2
SCHEMBL6091625 0.84 NPY5R (0.57) NPY5RSLC2A1POLA1MEN1KMT2A
SCHEMBL6234851 0.83 SMN1; SMN2 (0.71) SLC2A1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL6233225 0.83 POLB (0.51) NPY5RSLC2A1MEN1KMT2APOLB
SCHEMBL6235120 0.82 NPY5R (0.47) NPY5RSLC2A1POLA1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1430030-B1 N-TYPE CALCIUM CHANNEL ANTAGONISTS FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2005-05-18 EP disclosed